Evidence map›Paper›PMID 33960676›Full record

Trial reportInternational wound journal2021

Effectiveness of skin cleanser and protectant regimen on incontinence-associated dermatitis outcomes in acute care patients: A cluster randomised trial.

George Frederick Glass, Cheng Cheng Karine Goh, Run Qi Cheong, Zhi Lei Ong, Peck Chui Betty Khong, Ee-Yuee Chan

Erratum issuedOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in International wound journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
10.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Friction between human skin and incontinence pads in the presence of barrier protection products.Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine · 2024
    Article
  14. Review
  15. Efficacy of modified isolation in incontinence associated dermatitis.American journal of translational research · 2023
    Article
  16. Article
  17. Corrigendum.International wound journal · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

George Frederick GlassNursing Research Unit, Tan Tock Seng Hospital, Singapore, Singapore.ORCID https://orcid.org/0000-0003-0667-3954
Cheng Cheng Karine GohNursing Service, Tan Tock Seng Hospital, Singapore, Singapore.
Run Qi CheongNursing Research Unit, Tan Tock Seng Hospital, Singapore, Singapore.
Zhi Lei OngNursing Research Unit, Tan Tock Seng Hospital, Singapore, Singapore.
Peck Chui Betty KhongNursing Service, Tan Tock Seng Hospital, Singapore, Singapore.ORCID https://orcid.org/0000-0001-6679-8324
Ee-Yuee ChanNursing Research Unit, Tan Tock Seng Hospital, Singapore, Singapore.ORCID https://orcid.org/0000-0001-8662-4487
Tan Tock Seng Hospital · SGNational University of Singapore · SG

Funding

Skin Innovation Grant under the Industry Alignment Fund Pre-Positioning (Health & Biomedical Services Domain) Project (H17/01/a0/004), Agency for Science, Technology and Research (A*STAR) SIG 18037
6 · The paper itself

Abstract

Skin cleansers and protectants protect skin from incontinent matter to reduce the risk of incontinence-associated dermatitis (IAD), but their effectiveness treating established IAD in the tropics is unknown. We conducted an open-label cluster randomised trial to compare the effectiveness of a combined regimen of (1) specialised skin cleansers with disposable body wipes and (2) either an acrylic terpolymer (T1) or zinc oxide (T2) skin protectant against disposable body wipes and zinc oxide protectant (control) in promoting IAD healing and reducing the risk of deterioration. Eighty-four patients were recruited in a tertiary hospital in Singapore between April 2019 and January 2020 (T1: n = 23; T2: n = 37; Control: n = 24). Although not statistically significant, patients treated with T1 and T2 were 1.5 times as likely to experience IAD healing within seven days compared with the control (P = .66). Healing was more pronounced in participants with skin loss treated with T1 or T2. No treatment was superior in preventing IAD deterioration, the prevalence of which remained small (8%-14%). While skin cleaning and protectants reduced the overall risk of skin deterioration, the addition of skin cleansers enhanced IAD healing within a short period, an important consideration for future research examining IAD treatment in acute care.

Indexed as

DermatitisFecal IncontinenceUrinary IncontinenceEmollientsHumansSkin CareEmollientsdermatitisdermatologic agentsincontinence-associated dermatitisirritantwound healing

Identifiers

PMID33960676
PMCPMC8613386
OpenAlexW3158743426

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.